Scholarlink

<p>Sjögren’s disease (SjD) is marked by dysfunction of the salivary gland (SG) caused by epithelial cell death. However, the mechanism remains unclear. Here we discovered that NRIP1 was abnormally upregulated in SjD and formed a protein complex with estrogen receptor α (ERα) to inhibit saliva secretion and lead to epithelial cell death. NRIP1 interacted with ERα and altered the estradiol (E2)–ERα downstream signal in the SG epithelium. In the context of SjD, NRIP1–ERα suppressed aquaporin-5 (AQP5) expression and promoted MYC expression. The NRIP1–ERα complex bound to the estrogen response elements of the <i>AQP5</i> promoter, leading to the downregulation of AQP5 expression and reduced SG secretion. Conversely, the NRIP1–ERα complex bound to the estrogen response elements of the <i>MYC</i> promoter, resulting in the upregulation of MYC expression. Furthermore, we demonstrated that elevated MYC levels promoted apoptosis and altered immune regulation and cell metabolism in SjD. <i>Nrip1</i>-knockout/ovariectomized mice did not develop the SjD phenotypes, confirming the role of NRIP1 in the pathophysiology of SjD. Molecular dynamic simulations revealed that NRIP1 competitively bound to ERα and masked the E2 binding site, providing structural insights into the disruption of hormonal signal. This study implicates NRIP1 as a potent diagnosis parameter and provides a putative target for SjD management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

NRIP1 disrupts ERα signal in Sjögren’s disease via AQP5 suppression and MYC-driven salivary dysfunction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月13日

查看全文
  • Bo Chen,
  • Janak L. Pathak,
  • Xiuni Qin,
  • Xueyang Li,
  • Tianjiao Mao,
  • Xi Chen,
  • Wei Wei,
  • Nobumoto Watanabe,
  • Lijing Wang,
  • Kevin H. Mayo,
  • Jun Di,
  • Yongliang Huo,
  • Xiaomeng Li,
  • Jiang Li

摘要

Sjögren’s disease (SjD) is marked by dysfunction of the salivary gland (SG) caused by epithelial cell death. However, the mechanism remains unclear. Here we discovered that NRIP1 was abnormally upregulated in SjD and formed a protein complex with estrogen receptor α (ERα) to inhibit saliva secretion and lead to epithelial cell death. NRIP1 interacted with ERα and altered the estradiol (E2)–ERα downstream signal in the SG epithelium. In the context of SjD, NRIP1–ERα suppressed aquaporin-5 (AQP5) expression and promoted MYC expression. The NRIP1–ERα complex bound to the estrogen response elements of the AQP5 promoter, leading to the downregulation of AQP5 expression and reduced SG secretion. Conversely, the NRIP1–ERα complex bound to the estrogen response elements of the MYC promoter, resulting in the upregulation of MYC expression. Furthermore, we demonstrated that elevated MYC levels promoted apoptosis and altered immune regulation and cell metabolism in SjD. Nrip1-knockout/ovariectomized mice did not develop the SjD phenotypes, confirming the role of NRIP1 in the pathophysiology of SjD. Molecular dynamic simulations revealed that NRIP1 competitively bound to ERα and masked the E2 binding site, providing structural insights into the disruption of hormonal signal. This study implicates NRIP1 as a potent diagnosis parameter and provides a putative target for SjD management.